About this trial
This study evaluates a proposed community-based implementation strategy to scale up screening, identification, and intervention on Health-Related Social Needs (HRSN) among persons on Long-Acting Injectable Pre-exposure Prophylaxis (LAI-PrEP). To do so, (1) screening for HRSN will occur at provider visits every 4 months, (2) navigation and establishment of connections with community resources through collaboration with two established community-based organization (CBO) partners, and (3) development of a tracking system integrated into the Electronic Medical Record (EMR) for monitoring and assessment of referral outcomes.
Eligibility criteria
Qualifiers
18 years of age or older
Does not have HIV AND vulnerable for HIV infection per WHO, NHS, and CDC recommendations
On or initiating LAI-PrEP as part of standard of care prior to study participation
Identify as either a Black/Latine cisgender woman OR Black/Latine MSM OR Transgender or Nonbinary Individual
Disqualifiers
Less than 18 years old
Known HIV seropositive status or test positive at screening
Does not identify as one of the listed priority populations
Not fluent in either English or Spanish
Trial design
Treatments tested in this trial
- Not listed